Mutations in the gene GDAP1 are involved in the Charcot-Marie-Tooth disease (CMT) type 2 K and 4 A in humans that is characterized by progressive hypo- and demyelination resulting in motor and sensory neuropathy. Here, GDAP1 is linked to sensory peripheral neuropathy.